AndhraNews.net
Home » Business News » 2012 » April » April 4, 2012

Biofrontera AG:Ad hoc: Biofrontera AG: Distribution Agreement with Bipharma for Ameluz® in the Benelux


April 4, 2012 - London

Biofrontera AG / /Ad hoc: Biofrontera AG: Distribution Agreement with Bipharma for Ameluz® in the Benelux . Processed and transmitted by Thomson Reuters ONE.The issuer is solely responsible for the content of this announcement.

Leverkusen, 04 April 2012 - Biofrontera Pharma GmbH, a fully-owned subsidiary of Biofrontera AG, has today signed an exclusive agreement with Bipharma B.V. in Almere, The Netherlands, for the marketing and distribution of Ameluz® in The Netherlands, Belgium and Luxembourg. Biofrontera receives an immediate cost compensation of € 100,000 plus a very significant share of all net revenues of Bipharma's Ameluz® sales. Further details are published in a parallel press release.

Biofrontera AG, Hemmelrather Weg 201, 51377 Leverkusen
ISIN: DE0006046113
WKN: 604611

Contact:
Anke zur Mühlen
Biofrontera AG
Tel.: +49 (0214) 87 63 20, Fax.: +49 (0214) 87 63 290
E-mail: a.zurmuehlen@biofrontera.com




This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients.

The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and other applicable laws; and
(ii) they are solely responsible for the content, accuracy and originality of the
information contained therein.

Source: Biofrontera AG via Thomson Reuters ONE

HUG#1600067

GlobeNewswire

Comment on this story

Share